Controlled gene product delivery from a regulatable retroviral vector
AssigneeThe General Hospital Corporation
InventorSteven A. Reeves
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe General Hospital Corporation
InventorSteven A. Reeves
Estimating the term…
An inducible or regulatable retroviral vector for the controlled delivery of a gene product, and in particular, a tetracycline regulated retroviral vector for the controlled delivery of a gene product is disclosed. This retroviral vector contains the following DNA sequences operatively linked from 5' to 3': (a) DNA comprising a first promoter; (b) DNA comprising a second promoter different from the first promoter in (a) and different from the third promoter in (e); (c) DNA encoding a tetracycline regulator unit (tTA) under the transcriptional control of the second promoter; (d) DNA comprising a tetracycline response unit (tetO) in an antisense orientation relative to the DNA encoding the regulator unit of (c); and (e) DNA comprising a third promoter different from the first promoter in (a) and different from the second promoter in (b) wherein the DNA comprising the response unit (d) is comprised within the third promoter.
A tetracycline regulated retroviral vector for expressing a coding sequence, the vector comprising the following DNA sequences operatively linked from 5' to 3':
A tetracycline regulated retroviral vector for expressing a coding sequence, the vector comprising the following DNA sequences operatively linked from 5' to 3':
Dependencies are inferred from the claim text.